Hyeon Woong Kang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Patient Reported Outcomes

Reactive Oxygen Species

Top Venues

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Myeong Jin Kim, Hyung Sun Kim, Hyeon Woong Kang, Da Eun Lee, Woosol Chris Hong, Ju Hyun Kim, Minsoo Kim, Jae-Ho Cheong, Hyo Jung Kim, Joon-Seong Park
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer. Cells 12 (20) (2023)
Hyeon Woong Kang, Joo Hyun Kim, Da Eun Lee, Yun Sun Lee, Myeong Jin Kim, Hyung Sun Kim, SungSoon Fang, Bo Eun Lee, Kyung-Jin Lee, Jongman Yoo, Hyo Jung Kim, Joon-Seong Park
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer. Cancer biology & therapy 24 (1) (2023)